A Clinical Study of Hyperthyroidism in Children

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age29-14
SponsorShengjing Hospital

About this trial

This study intends to conduct a retrospective and prospective study on children with hyperthyroidism, and it is a non-intervention study to collect information on diagnosis and treatment and long-term follow-up of children with hyperthyroidism. To investigate the clinical characteristics, treatment effect, side effects and remission of hyperthyroidism in children, to analyze the predictive factors for the effect of antithyroid drug treatment, remission and recurrence after drug withdrawal, and to explore the risk factors related to the occurrence of antithyroid drug-related adverse reactions.

Eligibility criteria

Qualifiers

Age ≤14 years old

Initial diagnosis of hyperthyroidism

Disqualifiers

Hyperthyroidism had been treated with medication in other hospitals,

History of autoimmune hepatitis, viral hepatitis, hematological diseases, bone marrow or liver transplantation,

Patients with incomplete clinical data

Trial design

Treatments tested in this trial

  • Methimazole(MMI)

Treatment groups

No treatment groups listed

Sponsors and collaborators